pricing transparency

It is not surprising that pharmaceutical companies have filed a lawsuit seeking to block the implementation of the FDA’s new regulations regarding pricing information in direct to consumer (DTC) pharmaceutical advertising.
ACSH relies on donors like you. If you enjoy our work, please contribute.

Make your tax-deductible gift today!

 

 

Popular articles